Chronic obstructive pulmonary disease: Differences between men and women;Enfermedad Pulmonar Obstructiva: Diferencias Entre Hombres Y Mujeres

Medicina (Argentina)

Volumn 72, Issue 3, 2012, Pages 207-215

  Rodríguez Pecci, María Soledad ^a   de la Fuente Aguado, Javier ^a   Montero Tinnirello, Javier ^a   Sanjurjo Rivo, Ana B ^a   Sánchez Conde, Paula ^a   Fernández Fernández, Francisco J ^a  

^a HOSPITAL POVISA   (Spain)

Author keywords

Cardiovascular; COPD; Differences; Sex

Indexed keywords

CIGARETTE SMOKE;

ANKLE BRACHIAL INDEX; ANXIETY; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DISEASE SEVERITY; EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYMPTOM;

AGED; ANXIETY; ARGENTINA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84864010741     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50.
2. Lopez AD, Shibuya K, Rao C, Mathers CD. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
3. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30: 993-1013.
4. Sobradillo V, Miravitlles M, Gabriel R, Masa JF, Viejo JL, Fernández-Fau L. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC Multicentre Epidemiological Study. Chest 2000; 118: 981-9.
5. Miravitlles M, Soriano JB, Garcia-Rio R, et al. Prevalence of COPD in Spain: impact o; undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64:863-68.
6. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Op in Pulm Med 2004; 10: 98-103.
7. Soriano JB, Maier WC, Egger P. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789-94.
8. Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and rehabilitation committee of the Canadian Thoracic Society. Chest 1999; 116: 306-13.
9. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001; 119: 1691-95.
10. Carrasco-Garrido P, Miguel-Diez J, Rejas-Gutierrez J. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med 2009; 9: 1471-9.
11. Suh D, Lau H, Pokras SM. Sex differences in ambulatory visits for chronic obstructive pulmonary disease, based on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey from 1995 to 2004. Resp Care 2008; 53: 1461-9.
12. Cote CG, Chapman KR. Diagnosis and treatment considerations for women with COPD. Int J Clin Pract 20093 3: 486-93.
13. Ferrari R, Tanni SE, Lucheta PA. Gender differences in predictors of health status in patients with COPD. J Bras Pneumol 2010; 36: 37-43.
14. Sin DD, Paul Man SF. Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality. Proc Am Thorac Soc 2005; 2: 8-11.
15. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567-72.
16. Engstrom G, Wollmer P, Hedblad B, Juul-Moller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914", Malmo, Sweden. Circulation 2001; 103: 3086-91.
17. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-14.
18. Curkendall SM, De Luise C, Jones JK, Lanes S. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
19. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 2002; 166: 333-9.
20. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Di. 2009; 4: 337-49.
21. Chen Y, Li Q, Johansen H. Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity. Int J Tuberc lung Dis 2009; 13: 394-9.
22. Graham Barr R, Celli BR, Mannino DM, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med 2009; 122: 348-55.
23. Huiart L, Erns P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-6.
24. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009) En: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003. Published Last Modified Date. Consultado el 8/02/2010.
25. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin F, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: 5-40.
26. Prignot J. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis 1987; 70: 1-7.
27. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Hypertension 2003; 42:1206-52.
28. American Diabetes Asociation. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010; 33: S62-S69.
29. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Circulation 2002; 106: 3143-373.
30. Expert Panel on the Identification Evaluation, and Treatment of Overweight in Adults. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults:Executive Summary. Am J Clin Nutr 1998; 68: 899-917.
31. Leng GC, Fowkers FG. The Edinburgh claudication questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101e-9.
32. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2007; 28: 2375-414.
33. Al-Qaisi M, Note DM, King DH, Kaddoura S. Ankle Brachial Pressure Index (ABPI): An update for practitioners. Vasc Health Risk Manag. 2009; 5: 833-41.
34. Manzano L, García-Díab JD, Gómez-Cerezo J, et al. Valor de la determinación del índice tobillo-brazo en pacientes de riesgo vascular sin enfermedad aterotrombótica conocida: estudio VITAMIN. Rev Esp Cardiol 2006; 59: 662-70.
35. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Treatment in Primary Care Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care. JAMA 2001; 286: 1317-24.
36. Group The EuroQol. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
37. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
38. Badia X, Roset M, Monserrat S. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc) 1999; 112: 79-86.
39. Agusti A, Calverley P, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122-36.
40. Camp PG, Coxon HO, Levy RD. Sex differences in emphysema and airway disease in smokers. Chest 2009; 136: 1480-8.
41. Lizak M, Singh S, Lubina S, Zembala M. Female and male chronic obstructive pulmonary disease patients with severe dyspnea do not profit less from pulmonary rehabilitation. Pol Arch Med Wewn 2008; 118: 413-8.
42. Laurin C, Lavoie K, Bacon S, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007; 132: 148-55.
43. Martinez F, Curtis J, Sciurba S, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243-52.
44. Izquierdo-Alonso JL, De Lucas P, Rodriguez JM, Rodriguez JP, Pons S. Características clínicas de dos poblaciones diagnosticadas de enfermedad pulmonar obstructiva crónica por criterios espirométricos GOLD o por el límite inferior de la normalidad. Revista de Patología Respiratoria 2010; 13: 159-64.
45. Hardie JA, Buist AS, Vollmer WM, Ellinseng I, Bakke PS, Morkve O. Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-22.
46. Mannino DM, Buist AS, Vollmer W.M. Chronic obstructive pulmonary disease in the older adult: What defines abnormal lung function? Thorax 2007; 62: 237-41.
47. Greaves l, Richardson L. Tobacco use, women, gender, and chronic obstructive pulmonary disease. Are the connections being adequately made? Proc Am Thorac Soc 2007; 4: 675-9.
48. Torres J, Cote CG, Lopez M, et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009; 33: 528-35.
49. Carlson C, Cushman M, Enright PL, Cauley J, Newman A. Hormone replacement therapy is associated with higher FEV1 in elderly women. Am J Respir Crit Care Med 2001; 163: 423-8.
50. Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramirez-Sarmiento A, Antó J, Gea J. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 542-6.
51. Birring S, Brightling C, Entwisle J, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers. A descriptive study. Am J Respir Crit Care Med 2002; 166: 1078-83.
52. Pederson A, Hoyak K, Mills S, Camp PG. Reflecting the changing face of chronic obstructive pulmonary disease. Sex and gender in public education materials on COPD. Proc Am Thorac Soc 2007; 4683-5.
53. Han M, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease. Why it matters. Am J Respir Crit Care Med 2007; 176: 1179-84.
54. Dales R, Mehdizadeh A, Aaron S, Vandemheen K, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006; 18: 319-22.
55. Calverley P, Anderson J, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Eng J Med 2007; 356: 775-89.
56. Lucas-Ramos P, Izquierdo-Alonso JL, Rodríguez-González Moro JM, et al. Cardiovascular risk factors in chronic obstructive pulmonary disease: Results of the ARCE Study. Arch Bronconeumol 2008; 238: 233-8.
57. MaClay JD, McAllister DA, MacNee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12: 634-41.
58. Antonelli-Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with COPD. Eur Respir J 1997;10: 2794-800.
59. Eapen D, Kalra G, Rifa, L, Eapen C, Merchan, M, Khan B. Raising HDL cholesterol in women. Int J Womens Health 2009; 9: 181-91.
60. Castagna O, Boussuges A, Nussbaum E, Marqueste L, Brisswalter J. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil 2008; 15: 270-7.
61. Sigvant B, Wiberg-Hedman K, Bergkvist D. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45: 1185-91.
62. Vavra A, Kibbe M. Women and peripheral arterial disease. Womens Health (Lond Engl). 2009; 5: 669-83.
63. Mc Grae Mc Dermott M, Fried L, Simonsick E. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning. The women's Health and Aging Study. Circulation 2000; 101:1007-12.
64. Brevetti G, Bucur R, Balbarini A. Women and peripheral arterial disease: same disease, different issues. J Cardiovasc Med 2008; 9: 382-8.
65. Silander K, Alanne M, Kristiansson K, et al. Gender differences in genetic risk profiles for cardiovascular disease. PloS One 2008; 3: 3615-30.
66. Winston G, Graham Barr R, Carrasquillo O, Bertoni A, Shea S. Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the multi-ethnic study of atherosclerosis (MESA). Diabetes Care 2009; 32:1467-9.
67. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007; 176: 1-44.
68. Kaur S, Stechuchack K, Coffman C, Allen K, Bastian L. Gender differences in health care utilization among veterans with chronic pain. JGIM 2007; 22: 228-33.